Azelis expands its pharmaceutical offering to customers in Malaysia and Singapore with exclusive distribution agreement with Evonik

Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, is appointed exclusive distributor for Evonik’s EUDRAGIT® functional polymers in Malaysia and Singapore, effective 1 April 2025. This partnership strengthens the longstanding relationship between Azelis and Evonik across several market segments and the globe and specifically strengthens their collaboration within the pharmaceutical industry in the region. 

• With Evonik’s innovative EUDRAGIT® functional polymers, Azelis can support customers in Malaysia and Singapore in optimising their solid dosage formulation performance

• This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific

• Evonik chose Azelis for its proven track record in India and for its agility, results-driven culture, and commitment to excellence 

EUDRAGIT® functional polymers offer a comprehensive range of solutions designed for advanced controlled drug delivery in oral solid dosage forms. These polymers enhance solubility, permeability, and protection of active ingredients throughout the gastrointestinal tract, enabling targeted drug release. With formulations supporting immediate, delayed, and sustained release, EUDRAGIT® helps pharmaceutical manufacturers achieve precise and effective drug delivery. 

This partnership aligns with Azelis’ strategic goal to expand its pharmaceutical offering in Southeast Asia with performant ingredients. Azelis’ proven track record in India, where it successfully introduced and expanded the EUDRAGIT® range from the ground up, has reinforced Evonik’s confidence in its expertise. Building on this success, Evonik has selected Azelis as its preferred partner to further grow its pharmaceutical business in Malaysia and Singapore. With a results-driven culture, technical proficiency, and commitment to excellence, Azelis is well-positioned to support pharmaceutical manufacturers in Malaysia and Singapore. 

Rapeeporn Sathitthammaporn, Senior Business Manager at Evonik, shares her enthusiasm for the collaboration:  

“We're delighted to strengthen our partnership with Azelis. Their eagerness to grow, agility, and long-term vision align perfectly with Evonik’s mission to provide innovative, effective solutions to the challenges of the future. We believe that their existing expertise and strategic alignment will facilitate the business transition and ensure optimum service to existing and new customers.” 

Visava Lertrojanapunya, Regional Managing Director, Southeast Asia at Azelis, comments:  

“We are grateful to Evonik for their continued trust in Azelis. This partnership aligns with our vision to build a robust pharmaceutical portfolio in Malaysia and Singapore. With our technical expertise, formulation support, and customer-first approach, we are committed to delivering innovative solutions that address the evolving needs of pharmaceutical manufacturers.”